19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)

March 5-8, 2012, Seattle

CROI 2012: Hormonal Contraception May Raise HIV Risk for Women, but Uncertainty Remains

Injectable hormonal contraception may raise the risk of HIV infection for women, but it does not appear to increase the risk of HIV disease progression in women with HIV, according to findings from 2 new studies presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle.alt

Read more:

CROI 2012: GS-7977 Rapidly Suppresses HCV, but Most Patients Relapse after Stopping Treatment

An interferon-free combination of the experimental polymerase inhibitor GS-7977 plus ribavirin potently and rapidly reduced hepatitis C virus (HCV) levels, but almost all patients experienced viral rebound after they stopped treatment, researchers reported Tuesday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle.alt

Read more:

CROI 2012: New Hepatitis C Drugs in Clinical Practice [VIDEO]

New therapies are leading to a "huge sea change" in the way infectious disease doctors are thinking about hepatitis C, Douglas Dieterich suggested at a press conference at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this week in Seattle.alt

Read more:

CROI 2012: Telaprevir and Boceprevir Improve Sustained Response Rates in HIV/HCV Coinfected Patients

Adding a first-generation HCV protease inhibitor to pegylated interferon/ribavirin dramatically increases the likelihood of 12-week sustained virological response among HIV/HCV coinfected people, researchers reported Tuesday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.alt

Read more:

CROI 2012: Broadly Neutralizing Antibodies Can Help Fight HIV [VIDEO]

Recent discoveries about broadly neutralizing antibodies are helping advance the field of HIV vaccine development, according to Dennis Burton from the Scripps Research Institute and the Ragon Institute of MGH, MIT, and Harvard, who presented the annual Bernard Fields Lecture on Monday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.alt

Read more: